TNFRSF17 and plasma cell myeloma: When the disease progress again in all the patients, the anti-BCMA expressions in myeloma cells was positive in Ptwith 2,5,7 and Ptwithout 2,4, whereas it was negative in Ptwith 1,6 and Ptwithout 6,8.